Pharmacokinetic and Pharmacodynamic Response after Intranasal Administration of Diazepam to Rabbits

Authors

  • ERIK BECHGAARD,

    Corresponding author
    1. Department of Pharmaceutics, The Royal Danish School of Pharmacy, Universitetsparken 2, 2100 Copenhagen Ø, Denmark
    Search for more papers by this author
  • SVEINBJÖRN GIZURARSON,

    1. Department of Pharmaceutics, The Royal Danish School of Pharmacy, Universitetsparken 2, 2100 Copenhagen Ø, Denmark
    2. Department of Pharmacy, University of Iceland, Hagi Hofsvallagata 53, 107 Reykjavik, Iceland
    Search for more papers by this author
  • ROLF K. HJORTKJÆR

    1. Department of Pharmaceutics, The Royal Danish School of Pharmacy, Universitetsparken 2, 2100 Copenhagen Ø, Denmark
    2. Dansk Toxicology Centre, ATV, Agern allé 15, 2970 Hørsholm, Denmark
    Search for more papers by this author

Department of Pharmacy, The Royal Danish School of Pharmacy, Universitetsparken 2, 2100 Copenhagen Ø, Denmark.

Abstract

Nasal application of drugs might be an alternative to intravenous administration in acute situations such as epileptic or fever seizures. In the search for a nasal formulation leading to a peak plasma concentration of diazepam at a tmax ≤5 min bioavailability in rabbits has been studied after intranasal administration of the drug in ten vehicles of different polarity.

The animals were dosed with 3 mg diazepam, dissolved in 100 μL vehicle, the solution being administered into both nostrils. The bioavailability, measured during the first 30 min, because periods after this are not relevant for acute treatment, was found to be between 49 and 62% for the four most promising vehicles, pure glycofurol 75, tetraethyleneglycol, poly(ethylene glycol) 200 and 30% glycofurol in tetraethyleneglycol. The tmax for these vehicles was achieved after 5 min, and they induced a very rapid pharmacodynamic response after 1.5 to 3.5 min. The bioavailability was reduced when more polar liquids such as ethanol and tween 20, or lipid oils, e.g. vegetable oil and miglyol 840 were added to the glycofurol. There was a good correlation between tmax and the induction of pharmacodynamic response.

These results suggest that nasal application of diazepam in a water-free low-molecular-weight glycol might be of clinical importance as an alternative to intravenous injection, especially in acute situations.

Ancillary